S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Alliance Pharma Share Forecast, Price & News

GBX 112.80
+0.80 (+0.71%)
(As of 07/4/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
172,859 shs
Average Volume
998,674 shs
Market Capitalization
£608.83 million
P/E Ratio
Dividend Yield
Price Target
GBX 137.50

Alliance Pharma MarketRank™ Forecast

Analyst Rating
3.00 Rating Score
21.9% Upside
GBX 137.50 Price Target
Short Interest
Dividend Strength
Based on Four Factors
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.17 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

Alliance Pharma logo

About Alliance Pharma (LON:APH) Stock

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

APH Stock News Headlines

The Alliance Pharma share price – where next?
7 top AIM market shares to buy now
Alliance Pharma plc (APH.L)
2 nearly penny stocks to buy in September
Alliance Pharma Regulatory News
Alliance Pharma PLC : Notice of AGM
Should I buy penny share Alliance Pharma?
Alliance Pharma now has consumer healthcare front and centre
India, Covid-19 and vaccine politics
Why the EU has fallen behind on vaccines
See More Headlines

Industry, Sector and Symbol

Drugs - Generic
Year Founded

Company Calendar

Ex-Dividend for 7/7 Dividend
Dividend Payable
Next Earnings (Estimated)

Price Target and Rating

Average Stock Price Forecast
GBX 137.50
High Stock Price Forecast
GBX 145
Low Stock Price Forecast
GBX 130
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Pretax Margin


Sales & Book Value

Annual Sales
£163.21 million
Cash Flow
GBX 5.38 per share
Book Value
GBX 52.50 per share


Free Float
Market Cap
£608.83 million

Alliance Pharma Frequently Asked Questions

Should I buy or sell Alliance Pharma stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Alliance Pharma stock.
View analyst ratings for Alliance Pharma
or view top-rated stocks.

What is Alliance Pharma's stock price forecast for 2022?

2 brokers have issued 1 year price targets for Alliance Pharma's stock. Their APH stock forecasts range from GBX 130 to GBX 145. On average, they predict Alliance Pharma's share price to reach GBX 137.50 in the next year. This suggests a possible upside of 21.9% from the stock's current price.
View analysts' price targets for Alliance Pharma
or view top-rated stocks among Wall Street analysts.

How has Alliance Pharma's stock performed in 2022?

Alliance Pharma's stock was trading at GBX 108.80 at the beginning of the year. Since then, APH stock has increased by 3.7% and is now trading at GBX 112.80.
View the best growth stocks for 2022 here

When is Alliance Pharma's next earnings date?

Alliance Pharma is scheduled to release its next quarterly earnings announcement on Monday, September 19th 2022.
View our earnings forecast for Alliance Pharma

How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma?

Alliance Pharma declared a dividend on Tuesday, March 22nd. Shareholders of record on Thursday, June 9th will be given a dividend of GBX 1.13 per share on Thursday, July 7th. This represents a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, June 9th. This is a boost from Alliance Pharma's previous dividend of GBX 0.56. The official announcement can be viewed at this link.
View Alliance Pharma's dividend history

Is Alliance Pharma a good dividend stock?

Alliance Pharma(LON:APH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 1.51%. The dividend payout ratio of Alliance Pharma is 163.70%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Alliance Pharma's dividend history.

Who are Alliance Pharma's key executives?

Alliance Pharma's management team includes the following people:
  • Mr. Peter Jonathan Butterfield, CEO & Exec. Director (Age 46, Pay $978.91k)
  • Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 56, Pay $417.2k)
  • Mr. Stephen Kidner, Chief Scientific Affairs & Operations Officer
  • Ms. Cora Maeve McCallum C.F.A., Head of Investor Relations & Corp. Communications
  • Mr. Alex Duggan, Chief Commercial & Corp. Devel. Officer
  • Ms. Janice Timberlake, Chief People & Infrastructure Officer
  • Mr. Steve Lobb, Head of Hydromol
  • Mr. David Hope, Head of Secondary Care
  • Mr. Rajiv Ghidiyal, Head of APAC, EMEA & Americas
  • Mr. Karim Husny, Head of International

What other stocks do shareholders of Alliance Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY).

What is Alliance Pharma's stock symbol?

Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH."

How do I buy shares of Alliance Pharma?

Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Alliance Pharma's stock price today?

One share of APH stock can currently be purchased for approximately GBX 112.80.

How much money does Alliance Pharma make?

Alliance Pharma (LON:APH) has a market capitalization of £608.83 million and generates £163.21 million in revenue each year.

How many employees does Alliance Pharma have?

Alliance Pharma employs 256 workers across the globe.

How can I contact Alliance Pharma?

Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The official website for Alliance Pharma is www.alliancepharma.co.uk. The company can be reached via phone at +44-1249-466966.

This page (LON:APH) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.